4//SEC Filing
KLEMP WALTER V 4
Accession 0001437749-25-033683
CIK 0001659617other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:24 PM ET
Size
8.2 KB
Accession
0001437749-25-033683
Insider Transaction Report
Form 4
KLEMP WALTER V
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2025-11-04$0.50/sh−7,001$3,479→ 765,356 total - Exercise/Conversion
Common Stock
2025-11-04+28,750→ 772,357 total - Exercise/Conversion
Restricted Stock Units
2025-11-04−28,750→ 2,380,731 total→ Common Stock (28,750 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- [F3]On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0000938419
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 8:24 PM ET
- Size
- 8.2 KB